Search Results - "Ersbøll, J"

Evaluation of bcl-2 protein expression and 14;18 translocation as prognostic markers in follicular lymphoma by PEZZELLA, F, JONES, M, RALFKIAER, E, ERSBØLL, J, GATTER, K. C, MASON, D. Y

“…Conflicting results have been published on the prognostic significance of t(14;18) in follicular lymphoma: Yunis et al. (1989) reported that its presence…”
Get full text

Risk of acute nonlymphocytic leukemia and preleukemia in patients treated with cyclophosphamide for non-Hodgkin's lymphomas. Comparison with results obtained in patients treated for Hodgkin's disease and ovarian carcinoma with other alkylating agents by Pedersen-Bjergaard, J, Ersbøll, J, Sørensen, H M, Keiding, N, Larsen, S O, Philip, P, Larsen, M S, Schultz, H, Nissen, N I

“…Of 602 patients treated for non-Hodgkin's lymphomas, 9 developed overt acute nonlymphocytic leukemia or preleukemia with refractory cytopenia and cytogenetic…”
Get more information

public health Single-arm trials for cancer drug approval and patient access by Martinalbo, J., Camarero, J., Delgado-Charro, B., Démolis, P., Ersbøll, J., Foggi, P., Jonsson, B., O'Connor, D., Pignatti, F.

Get full text

Carcinoma of the urinary bladder after treatment with cyclophosphamide for non-Hodgkin's lymphoma by Pedersen-Bjergaard, J, Ersbøll, J, Hansen, V L, Sørensen, B L, Christoffersen, K, Hou-Jensen, K, Nissen, N I, Knudsen, J B, Hansen, M M

“…We observed nine cases of transitional-cell carcinoma of the urinary bladder among patients who had had long-term treatment of other cancers with…”
Get more information

Teniposide and etoposide in previously untreated small-cell lung cancer: a randomized study by Bork, E, Ersbøll, J, Dombernowsky, P, Bergman, B, Hansen, M, Hansen, H H

“…A randomized study comparing teniposide (VM-26) and etoposide (VP-16) was performed to investigate whether there are any differences in the activity and…”
Get more information

BEAM+autologous stem cell transplantation in malignant lymphoma: 100 consecutive transplants in a single centre. Efficacy, toxicity and engraftment in relation to stem-cell source and previous treatment by Geisler, C. H., Hansen, M. Mørk, Andersen, N. S., Brown, P., Christensen, L. Dalh, Dickmeiss, E., Ersbøll, J., Myhre, J., Hansen, M., Juhl, B. Ravn, Mortensen, B. Thing, Pedersen-Bjergaard, J.

“…: One hundred consecutive patients with malignant lymphoma treated with high‐dose chemotherapy and autologous stem cell transplantation, followed at least 1 yr…”
Get full text

Acute Nonlymphocytic Leukemia, Preleukemia, and Acute Myeloproliferative Syndrome Secondary to Treatment of Other Malignant Diseases. Clinical and Cytogenetic Characteristics and Results of In Vitro Culture of Bone Marrow and HLA Typing by Pedersen-Bjergaard, Jens, Philip, Preben, Mortensen, Børge Thing, Ersbøll, Jens, Jensen, Grethe, Panduro, Jytte, Thomsen, Mogens

“…Thirty-one patients were studied with a clinical picture of preleukemia, acute myeloproliferative syndrome, or overt acute nonlymphocytic leukemia following…”
Get full text

Autologous stem cell transplantation. From bone marrow to selected blood stem cells: 100 consecutive procedures at a single center by Geisler, C H, Simonsen, A C, Mortensen, B T, Christensen, L D, Ersbøll, J K, Andersen, N S, Dickmeiss, E, Hansen, M M

“…One hundred consecutive autologous stem cell transplants are reported: Non-Hodgkin's lymphoma 51 cases, Hodgkin's disease 27 cases, acute leukaemia 14 cases,…”
Get more information

Comparison of the working formulation of non-Hodgkin's lymphoma with the Rappaport, Kiel, and Lukes & Collins classifications. Translational value and prognostic significance based on review of 658 patients treated at a single institution by Ersbøll, J, Schultz, H B, Hougaard, P, Nissen, N I, Hou-Jensen, K

“…Six hundred fifty-eight cases of previously untreated non-Hodgkin's lymphoma seen between 1970 and 1979 at the Medical Department, the Finsen Institute, were…”
Get more information

Histiocytic sarcomas and monoblastic leukemias. A clinical, histologic, and immunophenotypical study by Lauritzen, A F, Delsol, G, Hansen, N E, Horn, T, Ersbøll, J, Hou-Jensen, K, Ralfkiaer, E

“…Eight histiocytic sarcomas, identified by examination of more than 2000 malignant lymphomas, are described. For comparison, tumor infiltrates from five…”
Get more information

Therapy-related myelodysplasia and acute myeloid leukemia. Cytogenetic characteristics of 115 consecutive cases and risk in seven cohorts of patients treated intensively for malignant diseases in the Copenhagen series by Pedersen-Bjergaard, J, Philip, P, Larsen, S O, Andersson, M, Daugaard, G, Ersbøll, J, Hansen, S W, Hou-Jensen, K, Nielsen, D, Sigsgaard, T C

“…Therapy-related acute myeloid leukemia (t-AML), often presenting as myelodysplasia (t-MDS), has become the most serious long-term complication of cancer…”
Get more information

The European Medicines Agency Approval of Axitinib (Inlyta) for the Treatment of Advanced Renal Cell Carcinoma After Failure of Prior TreatmentWith Sunitinib or a Cytokine: Summary of the Scientific Assessment of the Committee for Medicinal Products for Human Use by Tzogani, K, Skibeli, V, Westgaard, I, Dalhus, M, Thoresen, H, Slot, KB, Damkier, P, Hofland, K, Borregaard, J, Ersboll, J

Get full text

The European Medicines Agency Approval of Axitinib (Inlyta) for the Treatment of Advanced Renal Cell Carcinoma After Failure of Prior Treatment With Sunitinib or a Cytokine: Summary of the Scientific Assessment of the Committee for Medicinal Products for Human Use by Tzogani, Kyriaki, Skibeli, Venke, Westgaard, Ingunn, Dalhus, Marianne, Thoresen, Hege, Slot, Karsten Bruins, Damkier, Per, Hofland, Kenneth, Borregaard, Jeanett, Ersbøll, Jens, Salmonson, Tomas, Pieters, Ronny, Sylvester, Richard, Mickisch, Gerald, Bergh, Jonas, Pignatti, Francesco

“…Axitinib is a tyrosine kinase inhibitor of vascular endothelial growth factor receptor 1 (VEGFR‐1), VEGFR‐2, and VEGFR‐3. Based on the positive opinion from…”
Get full text

The European Medicines Agency Review of Pertuzumab for the Treatment of Adult Patients With HER2‐Positive Metastatic or Locally Recurrent Unresectable Breast Cancer: Summary of the Scientific Assessment of the Committee for Medicinal Products for Human Use by Boix‐Perales, Hector, Borregaard, Jeanett, Jensen, Kristina Bech, Ersbøll, Jens, Galluzzo, Sara, Giuliani, Rosa, Ciceroni, Cinzia, Melchiorri, Daniela, Salmonson, Tomas, Bergh, Jonas, Schellens, Jan H., Pignatti, Francesco

“…Pertuzumab is a recombinant humanized monoclonal antibody that specifically targets the extracellular dimerization domain (subdomain II) of HER2. Based on the…”
Get full text

Priming with recombinant human hematopoietic cytokines before bone marrow harvest expands in vivo and enhances ex vivo recovery of myeloid progenitors in short-term liquid cultures by Johnsen, H E, Jensen, L, Gaarsdal, E, Hansen, P B, Ersbøll, J, Hansen, N E

“…Short-term liquid marrow cultures (STLMC) are a potential source for autografting. We have previously shown that the quality of such grafts from…”
Get more information

Summary of product characteristics--what is it and how is it used? by Ainsworth, M A, Ersbøll, J

Get more information

A randomized study of radiotherapy versus radiotherapy plus chemotherapy in stage I-II non-Hodgkin's lymphomas by Nissen, N I, Ersbøll, J, Hansen, H S, Walbom-Jørgensen, S, Pedersen-Bjergaard, J, Hansen, M M, Rygård, J

“…In a randomized, prospective trial from 1974-1978, 73 patients with non-Hodgkin's lymphomas in clinical Stage I or II were treated with extended field…”
Get more information

VP-16-213 in combination with cyclophosphamide, doxorubicin, vincristine, and prednisone in the treatment of non-Hodgkin's lymphomas by Hansen, M M, Bloomfield, C D, Jørgensen, J, Ersbøll, J, Pedersen-Bjergaard, J, Blom, J, Nissen, N I

“…VP-16-213 has been used in 5-day courses together with cyclophosphamide, doxorubicin (Adriamycin), vincristine, and prednisone for treatment of 74 consecutive…”
Get more information

Follicular low-grade non-Hodgkin's lymphoma: long-term outcome with or without tumor progression by Ersbøll, J, Schultz, H B, Pedersen-Bjergaard, J, Nissen, N I

“…Long-term outcome for 127 patients with follicular low-grade lymphoma was investigated. Therapy included radiotherapy (n = 23), low toxicity chemotherapy with…”
Get more information

Trovan (trovafloxacin/alatrofloxacin) recalled: why? How? by Stenver, D I, Ersbøll, J, Renneberg, J

Get more information